1.0Drug targetinghttps://sites.uef.fi/drug-targetingMain Research Projects - Drug targetingrich600338<blockquote class="wp-embedded-content" data-secret="fANJzA1tvx"><a href="https://sites.uef.fi/drug-targeting/projects/">Main Research Projects</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://sites.uef.fi/drug-targeting/projects/embed/#?secret=fANJzA1tvx" width="600" height="338" title="“Main Research Projects” — Drug targeting" data-secret="fANJzA1tvx" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://sites.uef.fi/drug-targeting/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
Our research group is developing novel transporter-utilizing (pro)drugs to: We are also interested in how to modulate specific transporters’ expression or function to regulate nutrient or toxin uptake e.g., into the brain or across the placenta that can affect the progression of neurological diseases or development of the fetus, respectively. We have recently also started […]https://sites.uef.fi/drug-targeting/wp-content/uploads/sites/59/2022/08/farmasia-kv-opiskelijat-2892-1024x683.jpg